These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 19307741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2005 Dec 01; 11(23):8341-7. PubMed ID: 16322294
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Hokita S, Xi H, Higashi H, Baldus SE, Metzger R, Brabender J, Bollschweiler E, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM.
    Oncol Rep; 2005 Jun 01; 13(6):1241-6. PubMed ID: 15870949
    [Abstract] [Full Text] [Related]

  • 4. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y.
    Ann Surg Oncol; 2010 Mar 01; 17(3):804-11. PubMed ID: 19885698
    [Abstract] [Full Text] [Related]

  • 5. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
    Joshi MB, Shirota Y, Danenberg KD, Conlon DH, Salonga DS, Herndon JE, Danenberg PV, Harpole DH.
    Clin Cancer Res; 2005 Mar 15; 11(6):2215-21. PubMed ID: 15788669
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma.
    Takatori H, Natsugoe S, Okumura H, Matsumoto M, Ishigami S, Owaki T, Aikou T.
    Oncol Rep; 2005 Apr 15; 13(4):697-701. PubMed ID: 15756444
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.
    J Am Coll Surg; 2005 Mar 15; 200(3):336-44. PubMed ID: 15737843
    [Abstract] [Full Text] [Related]

  • 8. Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas.
    Toh Y, Ohga T, Itoh S, Kabashima A, Yamamoto K, Adachi E, Sakaguchi Y, Okamura T, Hirata H.
    Anticancer Res; 2006 Mar 15; 26(3B):2487-91. PubMed ID: 16821637
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.
    Ann Surg Oncol; 2009 Sep 15; 16(9):2494-501. PubMed ID: 19526206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ.
    Ann Surg Oncol; 2007 Dec 15; 14(12):3602-9. PubMed ID: 17896157
    [Abstract] [Full Text] [Related]

  • 14. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Oncol Rep; 2006 Jun 15; 15(6):1417-23. PubMed ID: 16685374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T, Nibu K, Doi K, Inoue H, Saitoh M, Ohtsuki N, Makino K, Amatsu M.
    Acta Otolaryngol; 2007 Mar 15; 127(3):305-11. PubMed ID: 17364369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, Ogino T, Yoshida S.
    Jpn J Clin Oncol; 2005 Jun 15; 35(6):316-23. PubMed ID: 15961436
    [Abstract] [Full Text] [Related]

  • 19. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.
    Ann Surg Oncol; 2008 Feb 15; 15(2):576-82. PubMed ID: 18057993
    [Abstract] [Full Text] [Related]

  • 20. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.
    Anticancer Res; 2007 Feb 15; 27(2):851-6. PubMed ID: 17465211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.